1,749
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory disease

, , , , , , , & ORCID Icon show all
Article: 2163784 | Received 10 Aug 2022, Accepted 26 Dec 2022, Published online: 07 Jan 2023